
Elfunat in complex treatment of patients with portal hypertension in the early post-hemorrhagic period
Author(s) -
М. І. Тутченко,
Shu-Hsun Chub,
Tatiana Trofimova,
H.H. Roshchin,
V.V. Ridzhok
Publication year - 2021
Publication title -
medicina neotložnyh sostoânij
Language(s) - English
Resource type - Journals
eISSN - 2307-1230
pISSN - 2224-0586
DOI - 10.22141/2224-0586.17.3.2021.234800
Subject(s) - portal hypertension , cirrhosis , medicine , gastroenterology , anemia , hepatic encephalopathy , encephalopathy , period (music) , physics , acoustics
The paper deals with the results of the study of the effect of 2-ethyl-6-methyl-3-hydroxypyridine succinate (Elfunat) on erythroid lineage in patients with alcoholic liver cirrhosis and a history of gastroesophageal variceal bleeding. The study compared the impact on the central nervous system and blood values. The results of this study are important for the management of anemia and encephalopathy in this category of patients.